Cerebrolysin
FPF-1070 / Brain-Derived Peptide Preparation
Cerebrolysin is a porcine brain-derived peptide mixture consisting of low-molecular-weight neuropeptides and free amino acids obtained through standardized enzymatic proteolysis of pig brain proteins. It is approved in over 40 countries for the treatment of stroke, traumatic brain injury, and various forms of dementia, though it has not received FDA approval in the United States. Administration is exclusively via intravenous or intramuscular injection, with treatment protocols typically spanning 10-30 days.
작용 메커니즘
Porcine brain-derived peptide preparation containing low-molecular-weight neuropeptides and free amino acids. Exhibits neurotrophic activity mimicking BDNF, GDNF, NGF, and CNTF. Promotes neuronal sprouting, synaptogenesis, and neurogenesis. Reduces neuroinflammation.
연구 프로토콜
연구 용도만 사용 가능. 의학적 조언은 아닙니다.
Clinical protocols use 10-30ml IV infusion daily for 10-20 day cycles. Repeated every 3-6 months. Some protocols use 5-10ml intramuscularly. Not a single peptide — it is a standardized mixture.
연구 노트
Clinical Research Status
Cerebrolysin has been studied in numerous randomized controlled trials for acute ischemic stroke, traumatic brain injury, and vascular dementia. The CASTA trial and other large studies have shown mixed results, with some demonstrating improved functional outcomes while others failed to reach primary endpoints. It remains one of the most extensively studied neuropeptide preparations globally despite lacking FDA approval.
Key Published Findings
Research demonstrates neurotrophic activity similar to naturally occurring nerve growth factors, promoting neuronal sprouting, synaptic formation, and neurogenesis. Studies in Alzheimer's disease patients have shown improvements in cognitive function and global clinical assessments over 6-month treatment periods. Animal models consistently demonstrate reduced infarct volume and improved behavioral outcomes following induced stroke.
Safety Profile
The most common adverse effects include headache, dizziness, and injection site reactions, with serious adverse events occurring at rates similar to placebo in controlled trials. Allergic reactions are possible due to the porcine-derived nature of the product, though anaphylaxis is rare. It is contraindicated in patients with epilepsy, severe renal impairment, and known hypersensitivity to porcine proteins.
Comparison to Related Compounds
Unlike single-peptide nootropics such as Semax or Selank, Cerebrolysin is a complex mixture containing multiple bioactive fragments that may act synergistically on various neurotrophic pathways. Cortexin is a similar porcine brain-derived preparation but with distinct manufacturing processes and somewhat different peptide profiles. Compared to synthetic nootropics, Cerebrolysin's multi-target mechanism may offer broader neuroprotection but complicates mechanistic understanding.
Community Observations
Users frequently report improved mental clarity, enhanced recovery from brain injuries, and better cognitive function during treatment cycles. The requirement for IV/IM administration limits self-experimentation, and many users travel to countries where it is available over-the-counter. Cost and accessibility remain significant barriers, with some users sourcing from Eastern European or Asian pharmacies.
반감기
~Minutes (component peptides); neurotrophic effects last hours
재조성
Pre-mixed injectable solution (no reconstitution)
보관
건조한 상태
Room temperature up to 25C. Protect from light.
재조성된 상태
Use immediately after opening ampule. Single-use only.
미국 법적 상태
또는 알려진 이름으로
자주 묻는 질문
Cerebrolysin란 무엇인가요?
Cerebrolysin is a porcine brain-derived peptide mixture consisting of low-molecular-weight neuropeptides and free amino acids obtained through standardized enzymatic proteolysis of pig brain proteins. It is approved in over 40 countries for the treatment of stroke, traumatic brain injury, and various forms of dementia, though it has not received FDA approval in the United States. Administration is exclusively via intravenous or intramuscular injection, with treatment protocols typically spanning 10-30 days.
Cerebrolysin는 어떻게 작용하나요?
Porcine brain-derived peptide preparation containing low-molecular-weight neuropeptides and free amino acids. Exhibits neurotrophic activity mimicking BDNF, GDNF, NGF, and CNTF. Promotes neuronal sprouting, synaptogenesis, and neurogenesis. Reduces neuroinflammation.
Cerebrolysin의 미국 규제 현황은 어떤가요?
Not FDA-approved (approved in 40+ other countries)
Cerebrolysin의 반감기는 얼마인가요?
~Minutes (component peptides); neurotrophic effects last hours
Cerebrolysin의 다른 이름은 무엇인가요?
FPF-1070, Brain-Derived Peptide Preparation
Peptide Contacts는 정보 제공을 위해 연구 기반 요약을 제공합니다. 우리는 공급업체 문서를 호스팅, 배포하거나 지지하지 않습니다. 모든 테스트 보고서, GMP 인증서 및 공급업체 통신은 구매자는 직접 요청하고 확인해야 합니다. 이 플랫폼에서 제공되는 어떠한 정보도 법적, 의학적 또는 전문적인 조언을 대체하지 않습니다. 사용자는 모든 관련 지역법, 주법 및 연방법에 부합하기 위해 공급업체 자격 증명을 검증하고 구매하기 전에 준수해야 합니다. 이 플랫폼의 사용은 이러한 책임을 완전히 지닌 것으로 간주됩니다.
전체 공지사항 읽기